Работы, на которые ссылается эта работа

Работ: 15

Работа: COVID-19 Response in Uzbekistan: From RT-PCR Test System to the Clinical Trial of Subunit Vaccine

Correspondence - Tranexamic acid for traumatic brain injury
Sasieni, Peter D; id_orcid 0000-0003-1509-8744, Duffy, Stephen W, Cuzick, Jack
Статья2005Цитирований: 11
ABI
Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan
Mirzakamol S. Ayubov, Zabardast T. Buriev, Mukhammadjon K. Mirzakhmedov +5
СтатьяSARS-CoV-2 and COVID-19 ResearchPLoS ONE2022Цитирований: 9
ABI
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai, Tianyi Zheng, Kun Xu +18
Статья2020Цитирований: 8
ABI
Без названия
ДругоеЦитирований: 8
ABI
A new coronavirus associated with human respiratory disease in China
Fan Wu, Zhao Su, Bin Yu +16
Статья2020Цитирований: 8
ABI
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26
Статья2020Цитирований: 8
ABI
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman, Olfert Landt, Marco Kaiser +21
Статья2020Цитирований: 7
ABI
Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao +27
Статья2022Цитирований: 7
ABI
Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan
А. А. Абдуллаев, Abrorjon Abdurakhimov, Zebinisa Mirakbarova +6
СтатьяSARS-CoV-2 and COVID-19 ResearchPLoS ONE2022Цитирований: 6
ABI
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang, Yan Li, Lianpan Dai +26
Статья2021Цитирований: 6
ABI
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, Hana M. El Sahly, Brandon Essink +34
Статья2020Цитирований: 6
ABI
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, Glenda Gray, An Vandebosch +27
Статья2021Цитирований: 4
ABI
Challenges of COVID-19 testing in low-middle income countries (LMICs): the case of Malawi
Steven Munharo, Symon Fidelis Nayupe, Patrick Mbulaje +6
Статья2020Цитирований: 2
ABI
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future
Fausto Baldanti, Nirmal Kumar Ganguly, Guiqiang Wang +6
Обзорная статья2022Цитирований: 2
ABI
Review of Clinical Trials of COVID-19 Vaccination Booster in SARS-CoV-2 Variants Era: To Take It or Not To Take It
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Статья2022Цитирований: 2
ABI